Similar articles

• Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study.

  Makkink-Nombrado SV, Baak JP, Schuurmans L, Theeuwes JW, van der Aa T. Makkink-Nombrado SV, et al. Anal Cell Pathol. 1995 Apr;8(3):227-45. Anal Cell Pathol. 1995. PMID: 7547496
• [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].

  Ruibal A, Schneider J, Arias J, del Río MC, Núnez MJ, Tejerina A. Ruibal A, et al. Rev Esp Med Nucl. 2000 Jun;19(3):244-6. Rev Esp Med Nucl. 2000. PMID: 11062090 Spanish. No abstract available.
• [Prognostic factors in breast cancer patients].

  Roisman I, Peretz T, Reznick AZ, Lifshitz I, Bitterman A, Fares F, Toledano H, Barzilay A, Durst AL. Roisman I, et al. Harefuah. 1996 May 15;130(10):693-9. Harefuah. 1996. PMID: 8794662 Review. Hebrew. No abstract available.
• [Comparison of radiometric, immunometric, and immunohistochemical methods for the determination of hormonal receptors and quality control of other prognostic parameters in the characterization of carcinoma of the breast].

  Piffanelli A, Pelizzola D, Giovannini G, Catozzi L, Uccelli L, Barozzi R, Giganti M. Piffanelli A, et al. Pathologica. 1992 Nov-Dec;84(1094):61-4. Pathologica. 1992. PMID: 1363758 Italian. No abstract available.
• Prognostic factors in breast cancer.

  Elledge RM, McGuire WL, Osborne CK. Elledge RM, et al. Semin Oncol. 1992 Jun;19(3):244-53. Semin Oncol. 1992. PMID: 1351692 Review. No abstract available.